Experiment 69008

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEmpty organism
CitationLIU,G: OETTEL,L: RIPPLE,G: STAAB,MJ: HORVATH,D: ALBERTI,D: ARZOOMANIAN,R: MARNOCHA,R: BRUSKEWITZ,R: MAZESS,R: BISHOP,C: BHATTACHARYA,A: BAILEY,H:. (2002). PHASE I TRIAL OF 1-ALPHA-HYDROXYVITAMIN D-2 IN PATIENTS WITH HORMONE REFRACTORY PROSTATE CANCER.. 8(9)
Amount utilized
Compound isolated
DiseaseIN 25 PATIENTS WITH HORMONE REFRACTORY PROSTATE CANCER.
Dose amount5.0 MCG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE